8-K

Company

Ovid Therapeutics Inc.

Filed

July 10, 2025

Period of Report

July 10, 2025

Accession Number

0001628280-25-034733

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →